Literature DB >> 28574293

Evaluation of maternal serum hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia.

Ebru Alici Davutoğlu1, Asuman Akkaya Firat2, Ayşegül Ozel1, Nevin Yılmaz1, Isil Uzun3, Ilkbal Temel Yuksel4, Riza Madazlı1.   

Abstract

OBJECTIVE: To determine the serum levels of HIF-1 α, progranulin, and syndecan-1 in preeclampsia (PE) and normal pregnancy, and to compare whether these markers demonstrate any difference between early-onset PE (EO-PE) and late-onset PE (LO-PE).
METHODS: This cross-sectional study was conducted on 27 women with EO-PE, 27 women with LO-PE, and 26 healthy normotensive pregnant controls matched for gestational age. Maternal levels of serum HIF-1 α, progranulin, and syndecan-1 were measured with the use of an enzyme-linked immunosorbent assay kit.
RESULTS: Statistical analysis revealed significant differences between the control and the PE groups in progranulin (p < .001) and syndecan-1 (p <.001) levels. There were no significant differences in the serum HIF-1 α levels between these groups (p= .069). When PE patients were evaluated by considering subgroups; statistical analysis revealed significant inter-group differences in all biomarkers. Serum progranulin levels were significantly higher in LO-PE compared with the other two groups (EO-PE versus LO-PE and LO-PE versus controls p = .000). Control group presented significantly higher syndecan-1 levels, than EO and LO-PE (p < .001). HIF-1 α levels positively correlated with progranulin levels (r = .439, p= .000).
CONCLUSIONS: Serum progranulin may have potential to be used as a biomarker for the differentiation of EO-PE and LO-PE. The co-operative action between HIF-1 α and progranulin might play a key role in the pathogenesis of LO-PE. The predominant feature of LO-PE seems to be an inflammatory process, whereas in EO-PE placentation problem seems to be the main pathology.

Entities:  

Keywords:  Early-onset preeclampsia; hypoxia-inducible factor-1 α; late-onset preeclampsia; progranulin; syndecan-1

Mesh:

Substances:

Year:  2017        PMID: 28574293     DOI: 10.1080/14767058.2017.1333098

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

Review 1.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

Review 2.  A Systematic Review of Maternal Serum Syndecan-1 and Preeclampsia.

Authors:  Kitty George; Prakar Poudel; Roopa Chalasani; Mastiyage R Goonathilake; Sara Waqar; Sheeba George; Wilford Jean-Baptiste; Amina Yusuf Ali; Bithaiah Inyang; Feeba Sam Koshy; Lubna Mohammed
Journal:  Cureus       Date:  2022-06-09

Review 3.  Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas.

Authors:  Orsolya Oravecz; Andrea Balogh; Roberto Romero; Yi Xu; Kata Juhasz; Zsolt Gelencser; Zhonghui Xu; Gaurav Bhatti; Roger Pique-Regi; Balint Peterfia; Petronella Hupuczi; Ilona Kovalszky; Padma Murthi; Adi L Tarca; Zoltan Papp; Janos Matko; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

4.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

Review 5.  Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?

Authors:  Marina M Ziganshina; Ekaterina L Yarotskaya; Nicolai V Bovin; Stanislav V Pavlovich; Gennady T Sukhikh
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

6.  The prediction of early preeclampsia: Results from a longitudinal proteomics study.

Authors:  Adi L Tarca; Roberto Romero; Neta Benshalom-Tirosh; Nandor Gabor Than; Dereje W Gudicha; Bogdan Done; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Panaitescu; Dan Tirosh; Nardhy Gomez-Lopez; Sorin Draghici; Sonia S Hassan; Offer Erez
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

Review 7.  "What's in a name?": Exploring inconsistent and contradictory definitions and clinical guidelines for hypertensive disorders of pregnancy from published literature from Nigeria and Bangladesh.

Authors:  Karen Kirk; Charlotte Warren
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.